Skip to main content
Top
Published in: Breast Cancer Research and Treatment 3/2002

01-06-2002

Trends in Breast Cancer Aggressiveness Before the Introduction of Mass Screening in Southeastern Netherlands 1975–1989

Authors: W.J. Louwman, P.J. van Diest, M.W.P.M. van Beek, R.F.M. Schapers, M.B.C.J.E. Tutein Nolthenius-Puylaert, J.P.A. Baak, J.W.W. Coebergh

Published in: Breast Cancer Research and Treatment | Issue 3/2002

Login to get access
Metadata
Title
Trends in Breast Cancer Aggressiveness Before the Introduction of Mass Screening in Southeastern Netherlands 1975–1989
Authors
W.J. Louwman
P.J. van Diest
M.W.P.M. van Beek
R.F.M. Schapers
M.B.C.J.E. Tutein Nolthenius-Puylaert
J.P.A. Baak
J.W.W. Coebergh
Publication date
01-06-2002
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 3/2002
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/A:1015842720190

Other articles of this Issue 3/2002

Breast Cancer Research and Treatment 3/2002 Go to the issue

Instructions for Authors

Instructions for Authors

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine